Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,684,000 | -35.5% | 94,615 | -50.0% | 0.02% | -42.3% |
| Q3 2020 | $7,263,000 | -56.0% | 189,197 | -50.5% | 0.03% | -21.2% |
| Q2 2020 | $16,504,000 | +30.5% | 382,050 | -21.2% | 0.03% | +3.1% |
| Q1 2020 | $12,648,000 | -11.4% | 484,560 | +6.0% | 0.03% | +10.3% |
| Q4 2019 | $14,282,000 | +76.2% | 457,022 | +46.9% | 0.03% | +81.2% |
| Q3 2019 | $8,104,000 | +13.8% | 311,010 | -0.1% | 0.02% | +14.3% |
| Q2 2019 | $7,120,000 | – | 311,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |